Switch View
© Globe Newswire
26.08.2025
ISIN: US20678X1063
Conduit Pharmaceuticals Inc.
CDT
LISTED
NASDAQ
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy
News Preview
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US1850631045
Clearside Biomedical Inc
CLSD
LISTED
NASDAQ
Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress
News Preview
- Presentations Highlight the Versatility of Clearside’s SCS Microinjector® Platform for the Treatment of Multiple Retinal Diseases -...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ISIN: US07725L1026
BeOne Medicines Ltd.
ONC
LISTED
NASDAQ
BeOne to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025, with a fireside chat at 1:50 p.m. EDT.
The live webcast of this event can be accessed from the investors section of the Company’s website...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Newsfile
26.08.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group Announces 13th Consecutive Record Quarter, and Increased Positive Net Income from Operations
News Preview
Toronto, Ontario--(Newsfile Corp. - August 26, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada, is pleased to announce its unaudited financial results and corporate update for the fiscal quarter ended June 30th, 2025."In Q2 2025, Ha...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
26.08.2025
ISIN: US20454B1044
Compass Therapeutics Inc.
CMPX
LISTED
NASDAQ
Compass Therapeutics to Participate in Upcoming September Investor Events
News Preview
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of Se...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US3596161097
Fulcrum Therapeutics Inc
FULC
LISTED
NASDAQ
Fulcrum Therapeutics to Present at Upcoming Investor Meetings
News Preview
CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that company management will attend and present at the following i...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: CA10778Y1043
BriaCell Therapeutics Corp.
BCT
LISTED
TSX
BriaCell’s Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal
News Preview
PHILADELPHIA and VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced the publication of the mechanism of action of its next...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Altimmune to Participate in Upcoming Investor Conferences
News Preview
GAITHERSBURG, Md., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing peptide-based therapeutics for liver and cardiometabolic diseases, today announced that management will participate and be available for one-on-one meetings at the following investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US0327973006
Anavex Life Sciences Corp
AVXL
LISTED
NASDAQ
Anavex Life Sciences Reports New Publication in Medical Journal Highlighting the Established Precise Autophagy Mechanism with Blarcamesine
News Preview
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, an...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US68572M1062
Orchestra Biomed Holdings Inc
OBIO
LISTED
NASDAQ
Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology
News Preview
NEW HOPE, Pa., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the publication of data in the Journal of the American College of Cardiology: Clinica...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US23126K1060
Curanex Pharmaceuticals, Inc.
CURX
LISTED
NASDAQ
Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering
News Preview
Jericho, New York, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) ("Curanex" or the "Company"), a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases, today announced the pricing of its initial public offering (the “Offering”) of 3,750,000 shares...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US4884452065
Zevra Therapeutics Inc
ZVRA
LISTED
NASDAQ
Zevra Therapeutics to Participate at Upcoming Investor Conferences in September
News Preview
CELEBRATION, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra’s executive leadership team will participate in the following September events:...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
26.08.2025
ISIN: FR0004056851
Valneva SE
VLA
LISTED
EURONEXT
First Berlin Equity Research GmbH: Valneva SE | Rating: Buy
News Preview
Original-Research: Valneva SE - from First Berlin Equity Research GmbH
26.08.2025 / 11:25 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain......
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US2210061097
CorVel Corp
CRVL
LISTED
NASDAQ
The Save Mart Companies Honored for Transforming Workers’ Comp Program in Collaboration with CorVel
News Preview
FORT WORTH, Texas, Aug. 26, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a national provider of risk management solutions, congratulates its partner, The Save Mart Companies, one of the West Coast's largest regional, full-service grocery chains, for being named one of three recipients of the 2025 Workers’ Compensation Risk Manageme...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US98937L1052
Zenas BioPharma, Inc.
ZBIO
LISTED
NASDAQ
Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences
News Preview
WALTHAM, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for autoimmune diseases, today announced management’s presentations at the following i...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Telix to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference
News Preview
MELBOURNE, Australia and INDIANAPOLIS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) will present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 4:50 p.m. ET on Monday, September 8, 2025 (6:50 a.m. AEST, Sep 9) and at the H.C. Wainwright 27th Annual Global Investment Conference...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US30049G1040
Evoke Pharma Inc
EVOK
LISTED
NASDAQ
Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship
News Preview
Separately Secures Access to OneGI Through Brentwood Pharmacy Agreement...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US57055L1070
Marker Therapeutics, Inc.
MRKR
LISTED
NASDAQ
Marker Therapeutics Provides Update on Phase 1 APOLLO Study Highlighting Encouraging Overall Response Rates in Relapsed Lymphoma
News Preview
Ongoing Phase 1 APOLLO study investigating MT-601 in patients with relapsed B cell lymphoma showed 66% of Non-Hodgkin Lymphoma (NHL) patients achieving objective response rates, with 50% demonstrating complete response (CR)...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Regeneron Announces Positive Results from Phase 3 Trial in Generalized Myasthenia Gravis
News Preview
Cemdisiran monotherapy, dosed subcutaneously every three months, met the primary and key secondary endpoints, showing a 2.3-point placebo-adjusted improvement in Myasthenia Gravis Activities of Daily Living (MG-ADL) total score...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US87583X1090
Tango Therapeutics Inc
TNGX
LISTED
NASDAQ
Tango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
News Preview
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the 2025 Cantor Global Healthcare Conference on Wednesday, September 3 at 2:45-3:15 PM ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US30233G2093
EyePoint Pharmaceuticals Inc
EYPT
LISTED
NASDAQ
EyePoint Announces Participation at Upcoming Investor Conferences
News Preview
WATERTOWN, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that company management will participate at the following upcoming conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US92915B1061
Voyager Therapeutics Inc
VYGR
LISTED
NASDAQ
Voyager to Present at Upcoming Investor Conferences
News Preview
LEXINGTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced that the company will participate in the following upcoming investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US87164F1057
Syndax Pharmaceuticals Inc
SNDX
LISTED
NASDAQ
Syndax Announces Participation in September Investor Conferences
News Preview
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer, as well as members of the Syndax management team, will participate in the following upcoming investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US7867001049
Sagimet Biosciences Inc
SGMT
LISTED
NASDAQ
Sagimet Biosciences to Participate in Two Upcoming Investor Conferences
News Preview
SAN MATEO, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US03843E1047
Aquestive Therapeutics Inc
AQST
LISTED
NASDAQ
Aquestive Therapeutics to Participate in Upcoming September Investor Conferences
News Preview
WARREN, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, announced today that the management team will participate in three upcomin...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US82024L1035
Shattuck Labs Inc
STTK
LISTED
NASDAQ
Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
News Preview
— Aggregate net proceeds from private placement expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease (IBD) and potentially another autoimmune disease —...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US8793691069
Teleflex Inc
TFX
LISTED
NYSE
Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
WAYNE, Pa., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) will be presenting at the Morgan Stanley 23rd Annual Global Healthcare Conference at the Sheraton New York Times Square, on Tuesday, September 9, 2025, at 3:20 p.m. (ET)....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.08.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Michael Jordan's Game-Worn Sneakers Headline 'The Grail Collection' at Infinite Auctions (OTC Pink:MDCE)
News Preview
Five Iconic Michael Jordan Game-Worn Sneakers Headline Elite Sports Memorabilia Auction MESA, ARIZONA / ACCESS Newswire / August 26, 2025 / Infinite Auctions, a subsidiary of Medical Care Technologies Inc. (OTC PINK:MDCE), is proud to announce the "The Grail Collection," available exclusively at www.infiniteauctions.com. This highly antic...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted marketing authorization for Yeytuo® (lenacapavir)—the company’s twice-yearly injectable HIV-1 capsid inhibitor—for use as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolescents with increased HIV-1 acq...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.08.2025
ISIN: US83558L2043
Sonoma Pharmaceuticals, Inc.
SNOA
LISTED
NASDAQ
National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced
News Preview
BOULDER, CO / ACCESS Newswire / August 26, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and animal heal...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US0028241000
Abbott Laboratories
ABT
LISTED
NYSE
Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment
News Preview
Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for osteoporosis and cancer-related bone loss more affordable for millions of ThaisThis approval builds on Abbott's biosimilar portfolio in Asia Pacific, following recent launches in Malaysia and IndiaBANGKOK, Aug. 26, 2025 /PRNewswire/ -- Abbott (NYSE: ABT),...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US0028241000
Abbott Laboratories
ABT
LISTED
NYSE
Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment
News Preview
Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for osteoporosis and cancer-related bone loss more affordable for millions of ThaisThis approval builds on Abbott's biosimilar portfolio in Asia Pacific, following recent launches in Malaysia and IndiaBANGKOK, Aug. 26, 2025 /PRNewswire/ -- Abbott (NYSE: ABT),...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: CA75103L1013
Rakovina Therapeutics Inc.
RKV
LISTED
TSX
Rakovina Therapeutics CSO Dr. Mads Daugaard Invited to Present at the 13th Tuscany Retreat on Cancer Research and Apoptosis
News Preview
VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered drug discovery, today announced that Chief Scientific Officer Dr. Mads Daugaard has been invited to present this week at the 13t...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.08.2025
ISIN: CA0717341071
Bausch Health Companies Inc
BHC
LISTED
TSX
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
News Preview
LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and DURECT Corporation (NASDAQ:DRRX) today announced that BHC Lyon Merger Sub, Inc. ("Purchaser"), a wholly owned subsidiary of Bausch Health Americas, Inc. ("BHA"), an...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.08.2025
ISIN: US60785L2079
Modular Medical, Inc.
MODD
LISTED
NASDAQ
Modular Medical Announces Completion of MODD1 Cartridge Production and Commencement of Pivot Conversion
News Preview
-More than 6,000 MODD1 cartridges produced- Conversion to Pivot-ready manufacturing in preparation for product launch in 1Q26 SAN DIEGO, CA / ACCESS Newswire / August 26, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump d...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.08.2025
ISIN: GB00BYX3WZ24
Hemogenyx Pharmaceuticals plc
HEMO
LISTED
LSE
Hemogenyx raises £570,000 and Director's Dealing
News Preview
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN. LON...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US14070B1017
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
CAPR Stockholders with Large Losses Should Contact Robbins LLP Before the Lead Plaintiff Deadline for Information About Leading the Capricor Therapeutics, Inc. Class Action Lawsuit
News Preview
SAN DIEGO, Aug. 26, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between October 9, 2024 and July 10, 2025. Capricor is a clinical-stage biotechnology company that engages in the development of t...
Themefolio
Profiler
Peergroup
© EQS Newswire
26.08.2025
ISIN: DE000A2GS5D8
Dermapharm Holding SE
DMP
LISTED
XETR
Dermapharm bestätigt stabile Geschäftsentwicklung im ersten Halbjahr 2025 und verzeichnet EBITDA-Wachstum im zweiten Quartal gegenüber Vorjahresquartal
News Preview
Dermapharm bestätigt stabile Geschäftsentwicklung im ersten Halbjahr 2025 und verzeichnet EBITDA-Wachstum im zweiten Quartal gegenüber Vorjahresquartal
Stabiles erstes Halbjahr: Planmäßige Entwicklung beim Konzernumsatz und bei bereinigtem EBITDA.
Operative Stärke: EBITDA legt im zweiten Quartal 2025 um 3,7% gegenüber Vorjahresquartal zu.
Mar......
Themefolio
Profiler
Peergroup
© EQS Newswire
26.08.2025
ISIN: DE000A2GS5D8
Dermapharm Holding SE
DMP
LISTED
XETR
Dermapharm confirms stable business development in H1 2025 and records EBITDA growth in Q2 versus prior-year quarter
News Preview
Dermapharm confirms stable business development in H1 2025 and records EBITDA growth in Q2 versus prior-year quarter
Stable first six months: consolidated revenue and adjusted EBITDA in line with expectations.
Operational strength: EBITDA up 3.7% in Q2 2025 versus prior-year quarter.
Branded pharmaceuticals remain growth driver with strong EB......
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
BioArctic and Novartis sign an option, collaboration and license agreement using BrainTransporter™ for an upfront payment of USD 30 million plus additional potential milestones and royalties
News Preview
STOCKHOLM, Aug. 26, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the company has entered into an option, collaboration and license agreement with Novartis Pharma AG regarding a potential new treatment combining BioArctic's proprietary BrainTransporter technology with an undisclosed target in neurodegene...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
BioArctic and Novartis sign an option, collaboration and license agreement using BrainTransporter™ for an upfront payment of USD 30 million plus additional potential milestones and royalties
News Preview
STOCKHOLM, Aug. 26, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the company has entered into an option, collaboration and license agreement with Novartis Pharma AG regarding a potential new treatment combining BioArctic's proprietary BrainTransporter technology with an undisclosed target in neurodegene...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: SE0006887451
Corline Biomedical AB
CLBIO
LISTED
STO
Corline Biomedical AB offentliggör delårsrapport för perioden januari till juni 2025
News Preview
Corline Biomedical AB (”Corline”) publicerar härmed delårsrapporten för perioden januari till juni 2025. Nedan följer en kort sammanfattning av delårsrapporten. Fullständig rapport finns tillgänglig på Corlines hemsida samt som bifogad fil....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Publication of statement by the Board of Directors in respect of the takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Publication of offer document in respect of the takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira and lowering of minimum acceptance condition to 75%
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
NEOG Stockholders with Large Losses Should Contact Robbins LLP Before the Lead Plaintiff Deadline for Information About Leading the Neogen Corporation Class Action Lawsuit
News Preview
SAN DIEGO, Aug. 25, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Neogen Corporation (NASDAQ: NEOG) securities between January 6, 2023 and June 3, 2025. Neogen is a food safety company that manufactures and markets products and services dedicated to f...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPL
News Preview
NEW YORK, Aug. 25, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Replimune Group, Inc. ("Replimune" or the "Company")(NASDAQ: REPL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail a...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Align Technology, Inc. - ALGN
News Preview
NEW YORK, Aug. 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Align Technology, Inc. ("Align" or the "Company") (NASDAQ: ALGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. ...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
News Preview
NEW YORK, Aug. 25, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ: ALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are enc...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
News Preview
NEW YORK, Aug. 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© Newsfile
26.08.2025
ISIN: US68764Y2072
OS Therapies, Inc
OSTX
LISTED
XASE
OS Therapies Terminates Equity Line of Credit
News Preview
New York, New York--(Newsfile Corp. - August 25, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced that it terminated its Equity Purchase Agreement (the "ELOC") with Square Gate Capital Master Fund, LLC — S...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US31447E1055
Femasys Inc
FEMY
LISTED
NASDAQ
Femasys Announces Pricing of $8.0 Million Underwritten Public Offering
News Preview
ATLANTA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY) (the “Company” or “Femasys”), a leading biomedical innovator addressing significant unmet needs in women’s health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products, today announced the pricing of an underwritten public o...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: KYG0405D1051
Angelalign Technology Inc
6699
LISTED
HKSE
Angelalign Technology Announces First-Half 2025 Results While Increasing Investments in Legal, Supply Chain and Data Security
News Preview
SAN CLEMENTE, Calif., Aug. 26, 2025 /PRNewswire/ -- Angelalign Technology Inc. ("Angel" or the "Company") (6699.HK) announced its interim results for the first half of 2025. The Company delivered solid performance for the first six months of the year.
In the first half of 2025, Angel reported a year-over-year revenue increase of 33.1% to US$161....
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: KYG0405D1051
Angelalign Technology Inc
6699
LISTED
HKSE
Angelalign Technology Announces First-Half 2025 Results While Increasing Investments in Legal, Supply Chain and Data Security
News Preview
SAN CLEMENTE, Calif., Aug. 26, 2025 /PRNewswire/ -- Angelalign Technology Inc. ("Angel" or the "Company") (6699.HK) announced its interim results for the first half of 2025. The Company delivered solid performance for the first six months of the year.
In the first half of 2025, Angel reported a year-over-year revenue increase of 33.1% to US$161....
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Centene Corporation (CNC) Investors: September 8, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Centene Corporation (“Centene”) (NYSE: CNC) on behalf of those who purchased or otherwise acquired Centene securities between December 12, 2024, and June 30, 2025, inclusive (the “Class Period”). The...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ISIN: US14070B3096
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
CAPR INVESTORS: Kirby McInerney LLP Reminds Capricor Therapeutics, Inc. Investors of Important Deadline and Encourages Investors to Contact the Firm
News Preview
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) securities during the period of October 9, 2024 through July 10, 2025 inclusive (“the Class Period”).
If you suffered a loss on your Capricor investm...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US29337E1029
Enliven Therapeutics Inc
ELVN
LISTED
NASDAQ
Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2025 Annual Meeting
News Preview
BOULDER, Colo., Aug. 25, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced the Company will present data from its ENABLE Phase 1a/1b clinical trial of ELVN-001 in both an oral a...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: CA17104U1021
Christina Lake Cannabis Corp
CLC
LISTED
CSE
Christina Lake Cannabis Announces Intention to Amend Debentures
News Preview
VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) announces that it has initiated the process to amend the terms of an aggregate of $960,000 principal amount of convertible debenture (the "Debentures") of the...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Nutex Health Inc. (NUTX) Investors to Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Pe...
Themefolio
Profiler
Peergroup
© Newsfile
25.08.2025
ISIN: US09689V1008
Body and Mind Inc.
BAMM
LISTED
CSE
Body and Mind Inc. Announces Agreement to Divest from New Jersey
News Preview
Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - August 25, 2025) - Body and Mind Inc. (CSE: BAMM) (OTC: BMMJ) (the "Company" or "BaM") is pleased to announce the Company's wholly owned subsidiary, DEP Nevada, Inc. ("DEP") has entered into a Purchase Agreement with Ascend New Jersey, LLC (the "Purchaser"), whereby DEP, which own...
Themefolio
Profiler
Peergroup
© PR Newswire
25.08.2025
ISIN: US9467841055
Waystar Holding Corp.
WAY
LISTED
NASDAQ
Waystar Named Healthcare Company of the Year and Top-Ranked AI Software Platform in the 2025 Stevie® Awards
News Preview
Recognitions underscore breakthrough innovations, meaningful client outcomes at scale, and leadership driving healthcare's AI transformation
LEHI, Utah and LOUISVILLE, Ky., Aug. 25, 2025 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced it earned multiple Gold Stevie® Awards in the 2025 Inte...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
